Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Estrogen therapy for brain gray matter atrophy and associated disability

Estrogen therapy for brain gray matter atrophy and associated disability

US Patent 11865122 · Granted Jan 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Estrogen receptor ligand treatment for neurodegenerative diseases2023
Estrogen receptor ligands, compositions and methods related thereto2023
Estrogen receptor ligands, compositions and methods related thereto2021
Estrogen therapy for brain gray matter atrophy and associated disability2020
Estrogen combination for treatment of multiple sclerosis2020
Estrogen receptor ligand treatment for neurodegenerative diseases2020
Diarylpropionitrile therapy for treatment of multiple sclerosis2020
Methods of monitoring estriol therapy2019
Pharmaceutical packaging for estriol therapy2019
Compositions and methods for maintaining cognitive function2018
Pregnancy hormone combination for treatment of autoimmune diseases2016
Estriol therapy for multiple sclerosis and other autoimmune diseases2015